79 related articles for article (PubMed ID: 7656793)
1. [Ondansetron in the prophylaxis of acute emesis induced by supra-high single dose total body irradiation (TBI)].
Huang X; Guo N; Fan Y
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):64-6. PubMed ID: 7656793
[TBL] [Abstract][Full Text] [Related]
2. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced emesis: effects of ondansetron.
Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
[TBL] [Abstract][Full Text] [Related]
4. [Acute tolerance in hyperfractionated accelerated whole-body irradiation].
Latz D; Schraube P; Wannenmacher M
Strahlenther Onkol; 1996 Dec; 172(12):685-9. PubMed ID: 8992638
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
[TBL] [Abstract][Full Text] [Related]
6. Ondansetron for efficient emesis control during total body irradiation.
Schwella N; König V; Schwerdtfeger R; Schmidt-Wolf I; Schmid H; Riess H; Siegert W
Bone Marrow Transplant; 1994 Feb; 13(2):169-71. PubMed ID: 8205086
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron antiemetic therapy for chemotherapy and radiotherapy induced vomiting in children.
Sullivan MJ; Abbott GD; Robinson BA
N Z Med J; 1992 Sep; 105(942):369-71. PubMed ID: 1436837
[TBL] [Abstract][Full Text] [Related]
8. A review of ondansetron in the management of radiotherapy-induced emesis.
Roberts JT; Priestman TJ
Oncology; 1993; 50(3):173-9. PubMed ID: 8459988
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
[TBL] [Abstract][Full Text] [Related]
10. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
11. [Value of granisetron in the prevention of digestive disorders in total body irradiation].
Feuvret L; Jammet P; Campana F; Cosset JM; Fourquet A
Bull Cancer Radiother; 1994; 81(1):41-4. PubMed ID: 7893522
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
Hirabayashi N; Goto S; Morishima Y; Sao H; Matsuyama T; Kodera Y; Yamada H; Horibe K; Yano K; Kojima H; Ogura M; Tanimoto M; Morishita Y; Yazaki M; Utsumi M; Nagata K; Kato Y; Naoe T; Saito H
Rinsho Ketsueki; 1998 Jan; 39(1):21-6. PubMed ID: 9492549
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
16. Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy.
Cheirsilpa A; Ratanatharathorn V; Sinlarat P; Chindavijak K; Lousoontornsiri W; Chakrapee-Sirisuk S; Srimuninimit V
J Med Assoc Thai; 1994 Apr; 77(4):201-6. PubMed ID: 7844494
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
Campora E; Giudici S; Merlini L; Rubagotti A; Rosso R
Am J Clin Oncol; 1994 Dec; 17(6):522-6. PubMed ID: 7977174
[TBL] [Abstract][Full Text] [Related]
18. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
[TBL] [Abstract][Full Text] [Related]
19. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
[TBL] [Abstract][Full Text] [Related]
20. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
